Biblio
Export 1532 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is H [Clear All Filters]
“Mortality Risk after Diagnosis of Early-Onset Alzheimer's Disease versus Late-Onset Alzheimer's Disease: A Propensity Score Matching Analysis.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1341-1348, 2017.
, “Motor Phenotype in Neurodegenerative Disorders: Gait and Balance Platform Study Design Protocol for the Ontario Neurodegenerative Research Initiative (ONDRI).”, J Alzheimers Dis, vol. 59, no. 2, pp. 707-721, 2017.
, “Motor Phenotype in Neurodegenerative Disorders: Gait and Balance Platform Study Design Protocol for the Ontario Neurodegenerative Research Initiative (ONDRI).”, J Alzheimers Dis, vol. 59, no. 2, pp. 707-721, 2017.
, “mTORC2 (Rictor) in Alzheimer's Disease and Reversal of Amyloid-β Expression-Induced Insulin Resistance and Toxicity in Rat Primary Cortical Neurons.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1015-1036, 2017.
, “A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1159-1174, 2017.
, “Multimodal Cognitive Enhancement Therapy for Patients with Mild Cognitive Impairment and Mild Dementia: A Multi- Center, Randomized, Controlled, Double-Blind, Crossover Trial.”, J Alzheimers Dis, vol. 55, no. 2, pp. 787-796, 2017.
, “Multimodal Cognitive Enhancement Therapy for Patients with Mild Cognitive Impairment and Mild Dementia: A Multi- Center, Randomized, Controlled, Double-Blind, Crossover Trial.”, J Alzheimers Dis, vol. 55, no. 2, pp. 787-796, 2017.
, “Neuroimaging Feature Terminology: A Controlled Terminology for the Annotation of Brain Imaging Features.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1153-1169, 2017.
, “Neuroprotective Effect of TREM-2 in Aging and Alzheimer's Disease Model.”, J Alzheimers Dis, vol. 55, no. 1, pp. 199-217, 2017.
, “Neuropsychiatric Symptoms and Alzheimer's Disease Biomarkers Predict Driving Decline: Brief Report.”, J Alzheimers Dis, vol. 58, no. 3, pp. 675-680, 2017.
, “Neuropsychiatric Symptoms and Alzheimer's Disease Biomarkers Predict Driving Decline: Brief Report.”, J Alzheimers Dis, vol. 58, no. 3, pp. 675-680, 2017.
, “Neuropsychological Profile in the C9ORF72 Associated Behavioral Variant Frontotemporal Dementia.”, J Alzheimers Dis, vol. 58, no. 2, pp. 479-489, 2017.
, “Neuropsychological Profile in the C9ORF72 Associated Behavioral Variant Frontotemporal Dementia.”, J Alzheimers Dis, vol. 58, no. 2, pp. 479-489, 2017.
, “Neuropsychological Profile in the C9ORF72 Associated Behavioral Variant Frontotemporal Dementia.”, J Alzheimers Dis, vol. 58, no. 2, pp. 479-489, 2017.
, “Neuropsychological Profile in the C9ORF72 Associated Behavioral Variant Frontotemporal Dementia.”, J Alzheimers Dis, vol. 58, no. 2, pp. 479-489, 2017.
, “Neuropsychological Profile in the C9ORF72 Associated Behavioral Variant Frontotemporal Dementia.”, J Alzheimers Dis, vol. 58, no. 2, pp. 479-489, 2017.
, “Neuropsychological Profile in the C9ORF72 Associated Behavioral Variant Frontotemporal Dementia.”, J Alzheimers Dis, vol. 58, no. 2, pp. 479-489, 2017.
, “Neuropsychological Symptoms in Sporadic Creutzfeldt-Jakob Disease Patients in Germany.”, J Alzheimers Dis, vol. 59, no. 1, pp. 329-337, 2017.
, “Neurovascular Specifications in the Alzheimer-Like Brain of Mice Affected by Focal Cerebral Ischemia: Implications for Future Therapies.”, J Alzheimers Dis, vol. 59, no. 2, pp. 655-674, 2017.
, “Neurovascular Specifications in the Alzheimer-Like Brain of Mice Affected by Focal Cerebral Ischemia: Implications for Future Therapies.”, J Alzheimers Dis, vol. 59, no. 2, pp. 655-674, 2017.
, “No Genetic Overlap Between Circulating Iron Levels and Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 1, pp. 85-99, 2017.
, “Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization.”, J Alzheimers Dis, vol. 55, no. 1, pp. 159-170, 2017.
, “Novel Blood-Based Biomarkers of Cognition, Stress, and Physical or Cognitive Training in Older Adults at Risk of Dementia: Preliminary Evidence for a Role of BDNF, Irisin, and the Kynurenine Pathway.”, J Alzheimers Dis, vol. 59, no. 3, pp. 1097-1111, 2017.
, “A Novel Method for Direct Assessment of Everyday Competence Among Older Adults.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1229-1238, 2017.
, “Novel Phospho-Tau Monoclonal Antibody Generated Using a Liposomal Vaccine, with Enhanced Recognition of a Conformational Tauopathy Epitope.”, J Alzheimers Dis, vol. 56, no. 2, pp. 585-599, 2017.
,